4 Einträge gefunden

1. Maintenance of clinical response and consistent safety profile with up to 3 years of continuous treatment with guselkumab: Results from the VOYAGE 1 and VOYAGE 2 trials

   1. Reich, Kristian
   2. Griffiths, Christopher E M
   3. Gordon, Kenneth B
   4. Papp, Kim A
   5. Song, Michael
   6. Randazzo, Bruce
   7. Li, Shu

   2020 - Forschungsinformationssystem des UKE
2. Guselkumab Efficacy after Withdrawal Is Associated with Suppression of Serum IL-23-Regulated IL-17 and IL-22 in Psoriasis: VOYAGE 2 Study

   1. Gordon, Kenneth B
   2. Armstrong, April W
   3. Foley, Peter
   4. Song, Michael
   5. Shen, Yaung-Kaung
   6. Li, Shu
   7. Muñoz-Elías, Ernesto J

   2019 - Forschungsinformationssystem des UKE
3. Guselkumab versus secukinumab for the treatment of moderate-to-severe psoriasis (ECLIPSE): results from a phase 3, randomised controlled trial

   1. Reich, Kristian
   2. Armstrong, April W
   3. Langley, Richard G
   4. Flavin, Susan
   5. Randazzo, Bruce
   6. Li, Shu
   7. Hsu, Ming-Chun

   2019 - Forschungsinformationssystem des UKE
4. Consistent responses with guselkumab treatment in Asian and non-Asian patients with psoriasis: An analysis from VOYAGE 1 and VOYAGE 2

   1. Reich, Kristian
   2. Song, Michael
   3. Li, Shu
   4. Jiang, Jingzhi
   5. Youn, Sang Woong
   6. Tsai, Tsen-Fang
   7. Choe, Yong Beom

   2019 - Forschungsinformationssystem des UKE